Published • loading... • Updated
Trump administration announces drug pricing deals with Teva, Astellas and others
The agreements extend lower Medicaid drug prices to 26 companies and are projected to save Americans more than $600 billion over a decade, officials said.
- On Monday, President Donald Trump announced voluntary 'most-favored-nation' pricing agreements with nine mid-sized pharmaceutical firms, expanding the program to 26 manufacturers covering 90% of the domestic branded drug market.
- Trump launched the MFN policy via a May 12, 2025, executive order to align U.S. drug costs with international prices, crediting his 'America First' trade policy for compelling companies to invest in domestic production.
- These nine companies committed to invest at least $19.6 billion in U.S. manufacturing, while four firms agreed to donate 290 metric tons of active pharmaceutical ingredients to a federal strategic reserve to reduce foreign supply reliance.
- The administration projects the deals will save Americans more than $600 billion, though Public Citizen's Peter Maybarduk, access to medicines director, argued there is 'no evidence' companies followed through on prior commitments.
- Trump indicated the remaining 10% of the pharmaceutical market will have 'no choice' but to join the program, while the administration continues promoting TrumpRx, which officials claim has saved consumers more than $700 million since February.
Insights by Ground AI
84 Articles
84 Articles
Trump Announces Drug Pricing Deals Projected to Save Americans $600 Billion › American Greatness
President Donald Trump announced new agreements with major pharmaceutical companies Monday that he said will bring U.S. prescription drug prices in line with the lowest […] Source
·Phoenix, United States
Read Full Article
NEWS HEADLINES: WH announces 9 new agreements with pharma manufacturers aimed at slashing prescription drug costs for Americans – One America News Network
US President Donald Trump shakes hands with Richard Ascroft, CEO North America of Sun Pharma, during an announcement on Healthcare Affordability in the Oval Office of the White House in Washington, DC on August 31, 2026. (Photo by Brendan SMIALOWSKI / AFP via Getty Images) OAN Staff Brooke Mallory5:40 PM – Monday, August 31, 2026 In a major policy milestone for healthcare reform, President Donald Trump announced nine new agreements with pharmace…
Coverage Details
Total News Sources84
Leaning Left6Leaning Right26Center28Last UpdatedBias Distribution47% Center
Bias Distribution
- 47% of the sources are Center
47% Center
C 47%
R 43%
Factuality
To view factuality data please Upgrade to Premium
